122 related articles for article (PubMed ID: 37171007)
1. DTL is a Novel Downstream Gene of E2F1 that Promotes the Progression of Hepatocellular Carcinoma.
Dong R; Zhang D; Han B; Xu L; Zhang D; Cheng Z; Qiu X
Curr Cancer Drug Targets; 2023; 23(10):817-828. PubMed ID: 37171007
[TBL] [Abstract][Full Text] [Related]
2. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
3. SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1.
Chang L; Xi L; Liu Y; Liu R; Wu Z; Jian Z
Mol Med Rep; 2018 Jan; 17(1):342-349. PubMed ID: 29115436
[TBL] [Abstract][Full Text] [Related]
4. [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1].
Chen Y; Leng S; Wang Y
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):646-656. PubMed ID: 34289556
[No Abstract] [Full Text] [Related]
5. Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS1.
Ren X; Shen L; Gao S
J Environ Pathol Toxicol Oncol; 2024; 43(1):79-90. PubMed ID: 37824372
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms.
Jin Y; Liang ZY; Zhou WX; Zhou L
Hepatol Int; 2019 Mar; 13(2):180-189. PubMed ID: 30600477
[TBL] [Abstract][Full Text] [Related]
7. E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA.
Shen HM; Zhang D; Xiao P; Qu B; Sun YF
Cancer Gene Ther; 2023 Jul; 30(7):1007-1017. PubMed ID: 36973424
[TBL] [Abstract][Full Text] [Related]
8. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis.
Mu B; Lv C; Liu Q; Yang H
J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950
[TBL] [Abstract][Full Text] [Related]
10. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
[TBL] [Abstract][Full Text] [Related]
11. Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.
Wang SN; Wang LT; Sun DP; Chai CY; Hsi E; Kuo HT; Yokoyama KK; Hsu SH
Oncotarget; 2016 Jun; 7(24):36924-36939. PubMed ID: 27175585
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
13. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.
Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y
Front Immunol; 2022; 13():834606. PubMed ID: 35392073
[TBL] [Abstract][Full Text] [Related]
14. High glucose may promote the proliferation and metastasis of hepatocellular carcinoma via E2F1/RRBP1 pathway.
He Y; Huang S; Cheng T; Wang Y; Zhou SJ; Zhang YM; Yu P
Life Sci; 2020 Jul; 252():117656. PubMed ID: 32289433
[TBL] [Abstract][Full Text] [Related]
15. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway.
Yu Y; Zhao D; Li K; Cai Y; Xu P; Li R; Li J; Chen X; Chen P; Cui G
Cell Death Dis; 2020 Apr; 11(4):273. PubMed ID: 32332880
[TBL] [Abstract][Full Text] [Related]
16. SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma.
Zhang F; Lu J; Yang J; Dai Q; Du X; Xu Y; Zhang C
Immunogenetics; 2023 Feb; 75(1):39-51. PubMed ID: 36114381
[TBL] [Abstract][Full Text] [Related]
17. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
Pan Y; Wang B; Yang X; Bai F; Xu Q; Li X; Gao L; Ma C; Liang X
Sci Rep; 2015 Nov; 5():17006. PubMed ID: 26593394
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
[TBL] [Abstract][Full Text] [Related]
20. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
